Cart
sales@molnova.com
Isomeranzin
CAS No. 1088-17-1
Isomeranzin( Isomerazin )
Catalog No. M23292 CAS No. 1088-17-1
Isomeranzin has anti-inflammatory activity, it suppresses inflammation by inhibiting M1 macrophage polarization through the p65, NF-κB and ERK pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 226 | In Stock |
|
| 5MG | 250 | In Stock |
|
| 10MG | 369 | In Stock |
|
| 25MG | 607 | In Stock |
|
| 50MG | 835 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsomeranzin
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsomeranzin has anti-inflammatory activity, it suppresses inflammation by inhibiting M1 macrophage polarization through the p65, NF-κB and ERK pathway.
-
DescriptionIsomeranzin has anti-inflammatory activity, it suppresses inflammation by inhibiting M1 macrophage polarization through the p65, NF-κB and ERK pathway.
-
In Vitro——
-
In Vivo——
-
SynonymsIsomerazin
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK|NF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1088-17-1
-
Formula Weight260.3
-
Molecular FormulaC15H16O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (384.19 mM)
-
SMILESCC(C)C(Cc(c(O1)c(cc2)C=CC1=O)c2OC)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
AX-15836
A potent, highly selective ERK5 inhibitor with IC50 of 8 nM; shows little affinity for BRD4 (Kd=3.6 uM).
-
Ulixertinib hydrochl...
Ulixertinib hydrochloride (Ulixertinib HCl) is an orally available, selective and potent ERK1/2 inhibitor with anticancer and antitumor activity that inhibits the NB cell cycle and promotes apoptosis, and may be used in the study of solid tumors.
-
FR 180204
FR 180204 is a potent, selective, ATP-competitive ERK inhibitor with Ki of 0.31 and 0.14 uM for ERK1 and ERK2, respectively.
